Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.2M Buy
98,876
+13,262
+15% +$1.5M 0.09% 200
2025
Q4
$10.7M Buy
85,614
+6,005
+8% +$765K 0.1% 181
2025
Q3
$10.7M Buy
79,609
+14,671
+23% +$1.93M 0.1% 185
2025
Q2
$8.83M Buy
64,938
+10,141
+19% +$1.34M 0.1% 178
2025
Q1
$7.27M Buy
54,797
+19,898
+57% +$2.53M 0.11% 179
2024
Q4
$3.95M Buy
34,899
+8,098
+30% +$936K 0.07% 257
2024
Q3
$3.06M Sell
26,801
-23,688
-47% -$2.6M 0.08% 276
2024
Q2
$5.25M Buy
50,489
+25,823
+105% +$2.74M 0.14% 133
2024
Q1
$2.8M Sell
24,666
-180,951
-88% -$20.7M 0.06% 313
2023
Q4
$22.6M Buy
205,617
+19,176
+10% +$1.92M 0.57% 25
2023
Q3
$18.1M Buy
+186,441
New +$19.6M 0.56% 30

Other funds holding ABT

Vident Advisory's ABT Position: Q1 2026 in Review

Vident Advisory increased its Abbott (ABT) stake by 15% in Q1 2026, buying an estimated $1.5M and bringing the position to 98,876 shares worth $10.2M. The position accounts for 0.09% of the portfolio, ranked #200.

Vident Advisory first reported a position in ABT in Q3 2023 and has held it in 11 quarters since. The position peaked at $22.6M in Q4 2023. 3,085 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Vident Advisory held 98,876 shares of Abbott worth $10.2M as of Q1 2026.
  • Vident Advisory bought 13,262 Abbott shares in Q1 2026, an estimated $1.5M.
  • Abbott made up 0.09% of Vident Advisory's portfolio in Q1 2026, its #200 holding.
  • Vident Advisory first reported a position in Abbott in Q3 2023 and has held it in 11 quarters since.
  • Vident Advisory's Abbott position peaked at $22.6M in Q4 2023.
  • 3,085 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.